Target intelligence / Profile preview

Signal transducer and activator of transcription 2 (STAT2)

Target
STAT2
Molecular classification
Transcription factor, Signal transducer, Member of STAT protein family
01

Overview

Signal transducer and activator of transcription 2 (STAT2) is a transcription factor encoded by the STAT2 gene, critical for mediating cellular responses to Type I and Type III interferons (IFNs)[1][3]. In response to cytokine or growth factor signaling, STAT2 is phosphorylated by receptor-associated kinases (notably JAK1 and TYK2), forms a heterodimer with STAT1, and complexes with IRF9 to create the interferon-stimulated gene factor 3 (ISGF3) complex. This complex translocates to the nucleus to activate transcription of interferon-stimulated genes, which are essential for establishing an antiviral state and regulating immune responses[1][3][7]. Unlike other STAT proteins, STAT2 lacks DNA-binding capacity as a homodimer and functions primarily via its role in ISGF3. Mutations or deficiencies in STAT2 result in severe susceptibilities to viral infections and may be linked to rare forms of immunodeficiency[1]. Beyond classical interferon signaling, STAT2 also modulates the function of other STATs, acting as a negative regulator of STAT1 in certain cytokine pathways[7]. STAT2 interacts with several proteins including CREB-binding protein, IFNAR1, IFNAR2, IRF9, MED14, SMARCA4, and STAT1[1], and is essential for the transcriptional activation of antiviral and immunoregulatory genes.

Other names
STAT2ISGF3 (when part of the ISGF3 complex)Stat-2
02

Mechanism of action

For inhibitors of the JAK/STAT pathway, the mechanism involves inhibition of tyrosine phosphorylation and activation, thereby blocking STAT2-dependent transcriptional programs[3].

03

Biological functions

Signal transductionTranscription regulationInnate antiviral responseImmune response
04

Disease associations

ImmunodeficiencyInfection (notably viral infection)Cancer (as part of broader JAK/STAT pathway alterations)Other immune-related diseases
05

Safety considerations

Direct STAT2 inhibition could compromise antiviral immunity, raising concerns of infection susceptibility[1][3]Dysregulation of STAT2 may also perturb immune homeostasis
06

Interacting drugs

07

Biomarkers

Deficient STAT2 expression or function can serve as a biomarker for certain primary immunodeficiencies (e.g., Immunodeficiency 44)[1]Upregulation of STAT2-regulated genes is used as a readout of Type I interferon signaling activity

Beyond the preview

Go deeper on Signal transducer and activator of transcription 2 (STAT2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Signal transducer and activator of transcription 2 (STAT2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call